HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dial hand sanitizer sales could reach $20 mil. by year- end, firm tells analysts.

This article was originally published in The Rose Sheet

Executive Summary

DIAL ADVERTISING TOTALS $15 MIL. IN FIRST HALF, a significant increase compared to the firm's past marketing expenditures, Chairman and CEO Malcolm Jozoff told securities analysts during a conference call July 23. The increased advertising budget compares to "two years ago when the company spent practically nothing in terms of advertising," he said. With its heightened marketing efforts, Dial is "demonstrating its commitment to rebuild the fundamental brand equity on this trademark," Jozoff added. The firm believes its advertising expenditures are "solid and worthwhile" and is likely to continue backing its product line-up at this level.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005662

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel